Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

Astellas

Status and phase: Completed; Phase 4

Conditions: Coronary Artery Disease; Hypercholesteremia

Treatments: Drug: atorvastatin, Lipitor

Study type: Interventional

Funder types: Industry

Identifiers

NCT00408382

A5481/HOP1

Details and patient eligibility

About

To evaluate the efficacy of intensive lipid-lowering therapy with Lipitor on the changes of characteristics of yellow coronary plaque in subjects with hypercholesteremia accompanying coronary artery disease

Sex: All

Ages: 20 to 74 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with hypercholesteremia
• The indication of coronary angiography, coronary angioscopy and intravascular ultrasound are expected

Exclusion criteria

• Patients who has current administration of Lipitor or history of discontinued administration of Lipitor
• Acute cardiac infarction

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)